Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tioga Pharmaceuticals

Request full access

Kappa-opioid receptor agonist for pruritus and gastrointestinal diseases

San Diego, United StatesFounded 2005Biotech & Life Sciences

About Tioga Pharmaceuticals

Tioga Pharmaceuticals, Inc. was a privately held, venture-capital-backed biopharmaceutical company focused on developing therapeutics for gastrointestinal diseases and pruritus (itching). Founded in 2005 and headquartered in San Diego, CA, the company's primary drug candidate was asimadoline. Dr. Stuart Collinson, a partner at life science venture capital firm Forward Ventures, founded the company and served as its Executive Chairman. Collinson had previously been the CEO of Aurora Biosciences, which was acquired by Vertex Pharmaceuticals.

Asimadoline is an orally administered, highly selective kappa-opioid receptor agonist. Its selectivity was intended to provide therapeutic effects without the side effects associated with mu-opioid receptors. The company's development efforts centered on two main indications for asimadoline: diarrhea-predominant irritable bowel syndrome (D-IBS) and pruritus associated with conditions like atopic dermatitis. In 2011, the FDA granted Fast Track designation to asimadoline for the treatment of D-IBS. The company advanced the drug into Phase 3 clinical trials for this indication. Later, in 2015, Tioga initiated a Phase 2 proof-of-concept study for asimadoline in treating pruritus associated with atopic dermatitis.

Tioga Pharmaceuticals established licensing agreements to expand its reach. It granted Ono Pharmaceutical Co., Ltd. exclusive rights to develop and commercialize asimadoline in Japan, South Korea, and Taiwan. The company secured funding through multiple rounds, including a Series A round of $42 million and a Series B round of $10 million in 2012, bringing its total investor funding to $52 million. Key investors included Forward Ventures, Thomas, McNerney & Partners, and Innovate UK.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2005
Headquarters
San Diego, United States
Employees
2
Open positions
None listed
Dealroom signal
23.0/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2C

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Apr 2012 $10M $40M Genesys Capital · Thomas McNerney & Partners —
FundingOther financing Feb 2010 $18M — New Leaf Venture Partners · BB Biotech Ventures · Forward Ventures · Genesys Capital —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Tioga Pharmaceuticals website traffic

Latest recorded traffic for Tioga Pharmaceuticals is 1.1K monthly website visits, up 1122.2% over the last three months. Tioga Pharmaceuticals's team grew 0% over the past year.

Latest monthly visits1.1K 3-month web change+1122.2% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Tioga Pharmaceuticals in the San Diego ecosystem

Live from Dealroom

The Tioga Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Thomas McNerney & Partners
  • Genesys Capital

Other known investors3 additional known investors

  • BB Biotech Ventures
  • Forward Ventures
  • New Leaf Venture Partners
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tioga Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tioga Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.